134 related articles for article (PubMed ID: 6319575)
1. The pathogenicity of the M9 mutant of Semliki Forest virus in immune-compromised mice.
Gates MC; Sheahan BJ; Atkins GJ
J Gen Virol; 1984 Jan; 65 ( Pt 1)():73-80. PubMed ID: 6319575
[TBL] [Abstract][Full Text] [Related]
2. Semliki Forest virus-induced, immune-mediated demyelination: adoptive transfer studies and viral persistence in nude mice.
Fazakerley JK; Webb HE
J Gen Virol; 1987 Feb; 68 ( Pt 2)():377-85. PubMed ID: 3029281
[TBL] [Abstract][Full Text] [Related]
3. The pathogenicity of the A7, M9 and L10 strains of Semliki Forest virus for weanling mice and primary mouse brain cell cultures.
Gates MC; Sheahan BJ; O'Sullivan MA; Atkins GJ
J Gen Virol; 1985 Nov; 66 ( Pt 11)():2365-73. PubMed ID: 2997371
[TBL] [Abstract][Full Text] [Related]
4. Multiplication of virulent and demyelinating Semliki Forest virus in the mouse central nervous system: consequences in BALB/c and SJL mice.
Smyth JM; Sheahan BJ; Atkins GJ
J Gen Virol; 1990 Nov; 71 ( Pt 11)():2575-83. PubMed ID: 2174955
[TBL] [Abstract][Full Text] [Related]
5. Oligodendrocyte infection and demyelination produced in mice by the M9 mutant of Semliki Forest virus.
Sheahan BJ; Gates MC; Caffrey JF; Atkins GJ
Acta Neuropathol; 1983; 60(3-4):257-65. PubMed ID: 6310927
[TBL] [Abstract][Full Text] [Related]
6. Semliki Forest virus induced, immune mediated demyelination: the effect of irradiation.
Fazakerley JK; Webb HE
Br J Exp Pathol; 1987 Feb; 68(1):101-13. PubMed ID: 3028463
[TBL] [Abstract][Full Text] [Related]
7. Role of immune responses in protection and pathogenesis during Semliki Forest virus encephalitis.
Amor S; Scallan MF; Morris MM; Dyson H; Fazakerley JK
J Gen Virol; 1996 Feb; 77 ( Pt 2 )():281-91. PubMed ID: 8627232
[TBL] [Abstract][Full Text] [Related]
8. Semliki Forest virus (A7[74]) infection of adult mice induces an immune-mediated demyelinating encephalomyelitis.
Fazakerley JK; Khalili-Shirazi A; Webb HE
Ann N Y Acad Sci; 1988; 540():672-3. PubMed ID: 2849913
[No Abstract] [Full Text] [Related]
9. Immunoglobulin synthesis in nude (nu/nu), nu/+ and reconstituted nu/nu mice infected with a demyelinating strain of Semliki Forest virus.
Suckling AJ; Jagelman S; Webb HE
Clin Exp Immunol; 1982 Feb; 47(2):283-8. PubMed ID: 6280913
[TBL] [Abstract][Full Text] [Related]
10. Evidence for a T-cell related factor as the cause of demyelination in mice following Semliki Forest virus infection.
Jenkins HG; Tansey EM; Macefield F; Ikeda H
Brain Res; 1988 Aug; 459(1):145-7. PubMed ID: 2458803
[TBL] [Abstract][Full Text] [Related]
11. Semliki Forest virus infection of mice: a model for genetic and molecular analysis of viral pathogenicity.
Atkins GJ; Sheahan BJ; Dimmock NJ
J Gen Virol; 1985 Mar; 66 ( Pt 3)():395-408. PubMed ID: 2982998
[No Abstract] [Full Text] [Related]
12. Immunological reaction of the demyelinating Semliki Forest virus with immune serum to glycolipids and its possible importance to central nervous system viral auto-immune disease.
Webb HE; Mehta S; Gregson NA; Leibowitz S
Neuropathol Appl Neurobiol; 1984; 10(2):77-84. PubMed ID: 6328340
[TBL] [Abstract][Full Text] [Related]
13. Two mutations in the envelope glycoprotein E2 of Semliki Forest virus affecting the maturation and entry patterns of the virus alter pathogenicity for mice.
Glasgow GM; Sheahan BJ; Atkins GJ; Wahlberg JM; Salminen A; Liljeström P
Virology; 1991 Dec; 185(2):741-8. PubMed ID: 1660202
[TBL] [Abstract][Full Text] [Related]
14. Pathogenicity of Semliki Forest virus for the rat central nervous system and primary rat neural cell cultures: possible implications for the pathogenesis of multiple sclerosis.
Atkins GJ; Sheahan BJ; Mooney DA
Neuropathol Appl Neurobiol; 1990 Feb; 16(1):57-68. PubMed ID: 2157171
[TBL] [Abstract][Full Text] [Related]
15. Brain viral persistence and myelin damage in nude mice.
Chew-Lim M
Can J Comp Med; 1979 Jan; 43(1):39-43. PubMed ID: 427638
[TBL] [Abstract][Full Text] [Related]
16. Reconstitution of Semliki forest virus infected mice, induces immune mediated pathological changes in the CNS.
Fazakerley JK; Amor S; Webb HE
Clin Exp Immunol; 1983 Apr; 52(1):115-20. PubMed ID: 6305540
[TBL] [Abstract][Full Text] [Related]
17. Contrasting effects of immunosuppression on herpes simplex virus type I (HSV I) induced central nervous system (CNS) demyelination in mice.
Kastrukoff LF; Lau AS; Leung GY; Thomas EE
J Neurol Sci; 1993 Jul; 117(1-2):148-58. PubMed ID: 8410049
[TBL] [Abstract][Full Text] [Related]
18. Cyclosporine enhances virally induced T-cell-mediated demyelination. The effect of cyclosporine on a demyelinating virus infection.
Fazakerley JK; Webb HE
J Neurol Sci; 1987 Mar; 78(1):35-50. PubMed ID: 3033157
[TBL] [Abstract][Full Text] [Related]
19. Virus tropism, distribution, persistence and pathology in the corpus callosum of the Semliki Forest virus-infected mouse brain: a novel system to study virus-oligodendrocyte interactions.
Fazakerley JK; Cotterill CL; Lee G; Graham A
Neuropathol Appl Neurobiol; 2006 Aug; 32(4):397-409. PubMed ID: 16866985
[TBL] [Abstract][Full Text] [Related]
20. Modulation of a systemic Semliki Forest virus infection in mice by defective interfering virus.
Barrett AD; Dimmock NJ
J Gen Virol; 1984 Oct; 65 ( Pt 10)():1827-31. PubMed ID: 6092526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
